{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:53:33Z","timestamp":1790870013033,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1136\/ard.2003.008599","type":"journal-article","created":{"date-parts":[[2004,5,12]],"date-time":"2004-05-12T17:27:59Z","timestamp":1084382879000},"page":"681-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis"],"prefix":"10.1016","volume":"63","author":[{"given":"R","family":"Nissinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Leirisalo-Repo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Peltomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Palosuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Vaarala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2003.008599_bib1","series-title":"Arthritis and allied conditions. A textbook of rheumatology","first-page":"993","article-title":"Pathology of rheumatoid arthritis and associated disorders","author":"Hale","year":"1997"},{"key":"10.1136\/ard.2003.008599_bib2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Epstein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2003.008599_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia","volume":"330","author":"Tracey","year":"1987","journal-title":"Nature"},{"key":"10.1136\/ard.2003.008599_bib4","first-page":"297","article-title":"Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action","volume":"8","author":"Feldmann","year":"1997","journal-title":"Eur Cytokine Netw"},{"key":"10.1136\/ard.2003.008599_bib5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008599_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","article-title":"A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate","volume":"340","author":"Weinblatt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2003.008599_bib7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/art.1780390703","article-title":"Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis","volume":"39","author":"Paleolog","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008599_bib8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.170.5.1627","article-title":"Antibodies to cachectin\/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia","volume":"170","author":"Fong","year":"1989","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2003.008599_bib9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis","volume":"163","author":"Charles","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard.2003.008599_bib10","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008599_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ard.60.2.133","article-title":"Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors","volume":"60","author":"Berg","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.008599_bib12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1","article-title":"Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis","volume":"41","author":"Paleolog","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008599_bib13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008599_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000069460","article-title":"Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay","volume":"115","author":"Palosuo","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1136\/ard.2003.008599_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008599_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0090-1229(90)90167-O","article-title":"Interferon-gamma mRNA expression upon in vitro T lymphocyte activation is decreased in rheumatoid arthritis patients","volume":"56","author":"Sadouk","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1136\/ard.2003.008599_bib17","first-page":"1639","article-title":"Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus","volume":"15","author":"McKenna","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2003.008599_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/03009748709102926","article-title":"Reduced production of interferon alpha and interferon gamma in leukocyte cultures from patients with active rheumatoid arthritis","volume":"16","author":"Seitz","year":"1987","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2003.008599_bib19","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/ard.60.8.750","article-title":"Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha","volume":"60","author":"Baeten","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.008599_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI117394","article-title":"Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis","volume":"94","author":"Cope","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2003.008599_bib21","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.4049\/jimmunol.163.7.3653","article-title":"TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression","volume":"163","author":"Lane","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard.2003.008599_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0167-5699(98)01346-2","article-title":"Chemokines and chemokine receptors in T-cell priming and Th1\/Th2-mediated responses","volume":"19","author":"Sallusto","year":"1998","journal-title":"Immunol Today"},{"key":"10.1136\/ard.2003.008599_bib23","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3","article-title":"Distinct patterns and kinetics of chemokine production regulate dendritic cell function","volume":"29","author":"Sallusto","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2003.008599_bib24","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.4049\/jimmunol.164.12.6180","article-title":"TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes","volume":"164","author":"Hornung","year":"2000","journal-title":"J Immunol"},{"key":"10.1136\/ard.2003.008599_bib25","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.4049\/jimmunol.164.5.2285","article-title":"TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors","volume":"164","author":"Sato","year":"2000","journal-title":"J Immunol"},{"key":"10.1136\/ard.2003.008599_bib26","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.4049\/jimmunol.156.4.1646","article-title":"In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects","volume":"156","author":"Lorenz","year":"1996","journal-title":"J Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724188917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724188917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2003.008599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T13:48:49Z","timestamp":1736084929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724188917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0003496724188917"],"URL":"https:\/\/doi.org\/10.1136\/ard.2003.008599","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2003.008599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Copyright 2004 by Annals of the Rheumatic Diseases. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}